BCS Wealth Management Has $2.03 Million Holdings in Colgate-Palmolive Company $CL

Key Points

• BCS Wealth Management boosted its stake in Colgate‑Palmolive by 100.6% in Q4 to 25,636 shares, valued at about $2.03 million.
• Insiders have been net sellers: the COO sold 15,000 shares and, overall, insiders offloaded 184,683 shares (~$17.49 million) in the past three months, leaving insiders with 0.43% ownership.
• Dividend raised to $0.53 quarterly (annualized $2.12, yield ~2.5%), and analysts show a consensus "Moderate Buy" with an average target price of $95.56.

BCS Wealth Management boosted its stake in Colgate-Palmolive Company (NYSE:CL - Free Report) by 100.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 25,636 shares of the company's stock after purchasing an additional 12,856 shares during the quarter. BCS Wealth Management's holdings in Colgate-Palmolive were worth $2,026,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of CL. Brighton Jones LLC raised its stake in Colgate-Palmolive by 4.4% during the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company's stock worth $962,000 after acquiring an additional 450 shares in the last quarter. Woodline Partners LP raised its stake in Colgate-Palmolive by 76.3% during the first quarter. Woodline Partners LP now owns 46,361 shares of the company's stock worth $4,344,000 after acquiring an additional 20,062 shares in the last quarter. Schnieders Capital Management LLC. raised its stake in Colgate-Palmolive by 2.0% during the second quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company's stock worth $1,136,000 after acquiring an additional 245 shares in the last quarter. Nebula Research & Development LLC grew its holdings in shares of Colgate-Palmolive by 165.5% during the second quarter. Nebula Research & Development LLC now owns 10,326 shares of the company's stock worth $939,000 after purchasing an additional 6,437 shares during the last quarter. Finally, Sei Investments Co. grew its holdings in shares of Colgate-Palmolive by 21.7% during the second quarter. Sei Investments Co. now owns 657,093 shares of the company's stock worth $59,732,000 after purchasing an additional 116,968 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

Insider Buying and Selling

In related news, COO Panagiotis Tsourapas sold 15,000 shares of the company's stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $97.81, for a total value of $1,467,150.00. Following the sale, the chief operating officer directly owned 10,415 shares in the company, valued at $1,018,691.15. This represents a 59.02% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Sally Massey sold 15,851 shares of the business's stock in a transaction that occurred on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total value of $1,506,320.53. Following the completion of the transaction, the insider directly owned 13,751 shares in the company, valued at approximately $1,306,757.53. This trade represents a 53.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 184,683 shares of company stock valued at $17,486,693. Insiders own 0.43% of the company's stock.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $84.19 on Wednesday. The business's 50 day simple moving average is $90.60 and its 200 day simple moving average is $83.67. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $99.33. The stock has a market capitalization of $67.55 billion, a PE ratio of 32.13, a PEG ratio of 4.18 and a beta of 0.34. The company has a debt-to-equity ratio of 18.82, a current ratio of 0.83 and a quick ratio of 0.54.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, beating the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The business had revenue of $5.23 billion for the quarter, compared to analysts' expectations of $5.13 billion. During the same period in the prior year, the business posted $0.91 earnings per share. The firm's revenue was up 5.8% on a year-over-year basis. As a group, research analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Monday, April 20th will be issued a $0.53 dividend. The ex-dividend date is Monday, April 20th. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.52. This represents a $2.12 annualized dividend and a yield of 2.5%. Colgate-Palmolive's dividend payout ratio (DPR) is currently 79.39%.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the company. Piper Sandler reduced their price target on Colgate-Palmolive from $96.00 to $92.00 and set an "overweight" rating on the stock in a report on Wednesday, April 8th. The Goldman Sachs Group restated a "buy" rating and set a $100.00 price target on shares of Colgate-Palmolive in a report on Friday, February 20th. Jefferies Financial Group boosted their price target on Colgate-Palmolive from $85.00 to $91.00 and gave the stock a "hold" rating in a report on Monday, February 2nd. Barclays reduced their price target on Colgate-Palmolive from $88.00 to $79.00 and set an "equal weight" rating on the stock in a report on Tuesday. Finally, UBS Group reduced their price target on Colgate-Palmolive from $100.00 to $98.00 and set a "buy" rating on the stock in a report on Tuesday, April 7th. Eleven analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $95.56.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company's core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.